Reference priceEUR €577.50Original source price: INR 52,500.00. Converted estimates are available by currency selection.
| Brand | Mitem |
|---|---|
| Manufacturer | Dr. Pfleger Arzneimittel GmbH |
| Prescription required | Yes |
Mitem 20mg Instillationsset,1 x 1ST(Mitomycin)
Mitomycin
Description
Mitem 20mg Instillationsset,1 x 1ST(Mitomycin) is a medicine catalog record in the MediPriceHub database. Active ingredient: Mitomycin. Clinical use summary: See the Benefits field on this page for the product-specific indication or intended use. That field is kept separate from catalog metadata so users can distinguish clinical information from packaging information. Manufacturer or supplier: Dr. Pfleger Arzneimittel GmbH. Therapeutic category: Medicine Library > Oncology Medicines > Bladder Cancer Medicines. Pack information: 20, 1 x 1. Origin country or market: Germany. This page is for medicine catalog reference only and should be read together with the approved prescribing information in the patient or buyer's country.Benefits
ZUSDURI™ is indicated for the treatment of adult patients with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC).How to Use
Mitem 20mg Instillationsset Mitomycin 20mgSpecification
Active ingredient: Mitomycin. Pack size: 20, 1 x 1. Pack unit: box. Manufacturer: Dr. Pfleger Arzneimittel GmbH. Origin country: Germany. Source category: Medicine Library > Oncology Medicines > Bladder Cancer Medicines. Availability, prescription status, storage, and exact approved use may vary by country. Check the local product information before clinical or procurement decisions.Side Effects
Cancer medicines may cause fatigue, nausea, vomiting, diarrhea or constipation, appetite changes, mouth sores, rash, changes in blood counts, infection risk, liver or kidney test changes, bleeding risk, neuropathy, infusion reactions, or organ-specific toxicity depending on the medicine. Seek urgent medical care for severe allergic symptoms, breathing difficulty, fainting, severe skin reactions, chest pain, confusion, serious bleeding, signs of infection, or rapidly worsening symptoms. The approved local prescribing information is the controlling source for the complete adverse-reaction profile.Diese Angaben dienen nur als Referenz. Lassen Sie sich vor der Anwendung eines Medikaments von medizinischem Fachpersonal beraten.